An advisory panel for the U.S. Food and Drug Administration (FDA) recently approved the use of Gardasil, a vaccine for the human papillomavirus (HPV), for use in males. A new study, published yesterday in the British Medical Journal, found, however, that a public health campaign to vaccinate boys—in addition to girls, who have been receiving the vaccine in the U.S. since 2006—would not be cost-effective.
"What our results imply is for the resources expended, there may be better uses and other health interventions that would increase health gains in the population," Jane Kim of the Harvard School of Public Health, and an author of the study, told Reuters.
The vaccine helps to prevent against cervical cancer and genital warts, linked to certain strains of HPV, in females ages nine to 26. By administering it to males (recommended by the FDA panel also for ages nine to 26), proponents of the vaccine argue, it could protect boys and men from rare anal and penile cancers as well as genital warts—and slow the spread of the sexually transmitted disease.
Clinical trials have shown the vaccine to be both safe and effective in males. But, as Kim told Reuters, "Even though it might be beneficial, whether or not the benefits are worth the investment is what we sought to evaluate." Their calculations, based on trial data, health care and awareness campaign costs, as well as quality of life figures, found that the cost of launching a massive public health campaign to reach just as many boys as girls outweighed the economic benefits.
The cost-effectiveness of vaccinating boys, however, might prove to be better, Kim noted, if less than three quarters of girls get the vaccine. "If coverage in girls ends up being low," she told Reuters, "vaccinating boys became much more attractive." The authors also noted that their findings need not weight into the FDA's decision to approve the drug or a family's decision to have their son vaccinated.
Merck, which makes the vaccine, stands to earn an additional $300 million a year if the vaccine is extended to boys, Forbes reported last month.
Image courtesy of Wikimedia Commons/Jan Christian
You Might Also Like
Discuss This Article
Subscription Center
World Changing Ideas
-
Video ContestInnovation is the key to a better future. Enter your own World Changing Ideas videos in our contest.
Most Popular Blog Posts
9,000-year-old brew hitting the shelves this summer
Manipulative meow: Cats learn to vocalize a particular sound to train their human companions
Wylie Coywolf: The coyote-wolf hybrid has made its way to the Northeast
A lizard that swims through sand
Scientists urge EPA to assess potential phthalates risks
Editor's Pick
-
Time to Ban Production of Nuclear Weapons MaterialA new global treaty that cuts off production of plutonium and highly enriched uranium for nuclear weapons could jump-start nuclear disarmament and help prevent proliferation
Health & Medicine Newsletter
Get weekly coverage delivered to your inboxVideo
Podcasts
-
60-Second Science
RSS ·
iTunes
Botoxed Face Impairs Bad Feelings
click to enable
-
60-Second Science
RSS ·
iTunes
Distracted Customers' Wait Times Fly
click to enable



